April 1, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today announced that a Phase II Clinical Trial of ...

Clinical trials have four phases that test the safety and efficacy of various medical treatments on participants. Health insurance may cover some or all of the cost of participating in a clinical ...

A novel technique for treating GBM first underwent a phase 1 clinical trial with patients who had recurrence of their cancers ...

Triple Hair Group Inc. ("Triple Hair" or the "Company"), a company specializing in the development of innovative treatments for androgenic alopecia (pattern baldness), today announced that the first ...

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma ” or the “Company ”), a biopharmaceutical ...

The ongoing GARDian3 study is designed to assess whether a single subretinal administration of OCU410ST can slow structural ...

Clinical trials provide patients with relapsed or treatment-resistant lymphoma access to emerging therapies, making conversations with providers essential, according to Dr. Jennif ...

In this analysis, researchers aimed to quantify and bring attention to the time burden experienced by cancer patients enrolled in phase 2 clinical trials.

PALI-2108 demonstrated favorable safety and tolerability with no serious adverse events after two weeks of treatment in a difficult-to-treat populationPhase 1b data demonstrate endoscopic improvement, ...

Significant improvements in pain, function and patient global outcomes demonstrated LEVI-04 well tolerated and exhibits a favourable safety ...

The ongoing disruption in the Middle East is affecting a meaningful portion of global clinical research, with 6.7% of active ...